Pharma fears “lack of focus” on no-deal Brexit preparations

22 March 2019 - As Brexit is delayed, pharma suggests new measures to avoid no-deal drugs shortages. ...

Read more →

Drug company protections are latest stumbling block for NAFTA rewrite

21 March 2019 - President Trump’s ability to get his revised North American Free Trade Agreement through Congress may hinge ...

Read more →

Statement by FDA Commissioner on new strategies to modernise clinical trials to advance precision medicine, patient protections and more efficient product development

14 March 2019 - Modernizing clinical trials is an agency wide priority.  ...

Read more →

FDA medical adviser: 'Congress is owned by pharma'

13 March 2019 - Pharmaceutical companies are under the spotlight with congressional hearings on the cost of drug prices and ...

Read more →

AARP launches 'Stop Rx Greed' campaign targeting high prescription drug prices

12 March 2019 - Today, AARP announced the launch of 'Stop Rx Greed,' a nationwide campaign aimed at lowering prescription ...

Read more →

Firm in NHS row over cystic fibrosis drug paid almost no UK tax

6 March 2019 - European division of Vertex made loss while paying large sum to profitable US owner. ...

Read more →

Drug companies and doctors battle over the future of faecal transplants

3 March 2019 - As pharmaceutical companies seek to profit from the curative wonders of human faeces, doctors worry about new ...

Read more →

No one knows the true cost of medicines, and blaming other countries won't help

3 March 2019 - It’s not often that the Trump administration and the anti-poverty NGO Oxfam find themselves singing from the ...

Read more →

Drug industry CEOs say the problem isn’t high prices, it’s how misunderstood they are

28 February 2019 - It’s been a good week for political theatre.  ...

Read more →

“Repurposing” off-patent drugs offers big hopes of new treatments

28 February 2019 - Towards the end of 2014 a 66-year-old British man named Alistair had a seizure. A scan ...

Read more →

Senator: big pharma is 'morally repugnant'

26 February 2019 - Seven executives of top pharmaceutical companies were grilled before a congressional panel Tuesday about the nation's ...

Read more →

Pharma industry swamped with no-deal Brexit info, says BIA

27 February 2019 - Deluge comes just as prime minister hints at delay. ...

Read more →

Former Novartis executive wins $1.5 million after claiming she was fired for complaining about a study

26 February 2019 - Min Amy Guo, who had been executive director of the Health Economics and Outcomes Research Group, objected ...

Read more →

How pharma lost its edge in Washington

25 February 2019 - Major drug company CEOs are about to appear before Congress to address drug pricing—for the first time ...

Read more →

Hearings on 'sky-high' drug prices show how little has changed in 60 years

25 February 2019 - Kenneth Frazier, CEO of pharma giant Merck, is set to face senators Tuesday who say drug ...

Read more →